Protagen’s Cancer Immunotherapy Array will be used to identify autoantibody biomarkers that investigate the immunological profile and immuno-competence of long-term Glioblastoma survivors
Scientists developed a successful method to make truly personalized predictions of future disease outcomes for patients with certain types of chronic blood cancers